87 filings
Page 2 of 5
8-K
trjfwbsfow
8 Aug 23
Vigil Neuroscience Reports Second Quarter 2023 Financial Results and Provides Business Update
7:19am
8-K
l449vko vju71g
8 Jun 23
Submission of Matters to a Vote of Security Holders
5:12pm
8-K
0o1pht
10 May 23
Vigil Neuroscience Reports First Quarter 2023 Financial Results and Provides Business Update
7:14am
DEFA14A
zkq6qzyka vq9d
9 May 23
Additional proxy soliciting materials
8:42am
8-K
hwavpj d3r66i
9 May 23
Vigil Neuroscience Appoints Samantha Budd Haeberlein, Ph.D. to Board of Directors
8:15am
ARS
9k2socw 904z
27 Apr 23
Annual report to shareholders
7:11am
DEFA14A
jujzebnt3gm9wp3w
27 Apr 23
Additional proxy soliciting materials
7:07am
EFFECT
m3gx4epj4doq7omcu
31 Mar 23
Notice of effectiveness
12:15am
8-K
nd1rb91pcmsdtw
30 Mar 23
Vigil Neuroscience Announces FDA Has Lifted the Partial Clinical Hold on VGL101
7:10am
CORRESP
dhm 4jqs90fp91qj
28 Mar 23
Correspondence with SEC
12:00am
UPLOAD
so3 g3cjm22
27 Mar 23
Letter from SEC
12:00am
S-8
pou8 9n1zaqb8h
21 Mar 23
Registration of securities for employees
9:17am
S-3
ppzqkx3jqvpvzv6n
21 Mar 23
Shelf registration
7:53am
8-K
eanxm
21 Mar 23
Vigil Neuroscience Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
7:09am
8-K
b9xwehrtc0bw8pn
10 Mar 23
Regulation FD Disclosure
3:34pm
UPLOAD
u0yxv3ymicmwd52hp
28 Feb 23
Letter from SEC
12:00am